Brief: Response Genetics Q3 loss per share $0.09
13/11/2014 12:00
Nov 13 (Reuters) - Response Genetics Inc RGDX.O : * Announces third quarter 2014 financial results * Q3 loss per share $0.09 * Q3 revenue $4.5 million versus $4.1 million * Says expect pharma revenues to begin benefiting from the launch of testing services for the alchemist study * Source text for Eikon ID:nGNXVCBPDa * Further company coverage RGDX.O ((Bangalore Newsroom; +1 646 223 8780))
Recent news on Response Genetics
See all newsASX-listed Roto-Gro gains as Canniberia pre-approval triggers first order
Brief: Response Genetics entered third amendment to credit agreement dated July 30, 2014
Brief: Response Genetics Q4 loss per share $0.09
Brief: Response Genetics secures New York state department of health approval for testing services
Brief: Response Genetics Q3 loss per share $0.09